The Wnt/b-catenin signaling pathway is critical for normal mammalian development, the specification of epidermal cells and neoplastic transformation of intestinal epithelium. However, precise molecular information regarding cell-specific responses to b-catenin signaling has been limited. This question was addressed using a mouse model in which exon 3 of the b-catenin gene was deleted in several cell types with loxP-mediated recombination utilizing a Cre transgene under control of the mouse mammary tumor virus-long terminal repeat (MMTV-LTR). The stabilization of b-catenin in prostate epithelium resulted in hyperplasias and extensive transdifferentiation into epidermal-like structures, which expressed keratins 1 and 6, filaggrin, loricrin and involucrin. The cell-specific loss of NKCC1 protein and reduced nuclear Stat5a is further suggestive of a loss of prostate epithelial characteristics. In addition to the prostate, hyperplasias and squamous metaplasias were detected in epithelia of the epididymis, vas deferens, coagulating gland, preputial gland and salivary gland. However, and in contrast to a recent study, no lesions reminiscent of highgrade prostate intraepithelial neoplasia were detected. Since b-catenin was activated in several cell types and impinged upon the viability of these mice, it was not possible to evaluate the cumulative effect over more than 3 months. To assess long-term consequences of b-catenin activation, mutant and control prostate tissues were transplanted into the mammary fat pads of wild-type males. Notably, squamous metaplasias, intra-acinous hyperplasia and possible neoplastic transformation were observed after a total of 18 weeks of b-catenin stimulation. This suggests that the transdifferentiation into squamous metaplasias is an early response of endodermderived cells to b-catenin, and that the development of intra-acinous hyperplasias or neoplastic foci is a later event.
The Wnt/b-catenin signaling pathway is critical for normal mammalian development, the specification of epidermal cells and neoplastic transformation of intestinal epithelium. However, precise molecular information regarding cell-specific responses to b-catenin signaling has been limited. This question was addressed using a mouse model in which exon 3 of the b-catenin gene was deleted in several cell types with loxP-mediated recombination utilizing a Cre transgene under control of the mouse mammary tumor virus-long terminal repeat (MMTV-LTR). The stabilization of b-catenin in prostate epithelium resulted in hyperplasias and extensive transdifferentiation into epidermal-like structures, which expressed keratins 1 and 6, filaggrin, loricrin and involucrin. The cell-specific loss of NKCC1 protein and reduced nuclear Stat5a is further suggestive of a loss of prostate epithelial characteristics. In addition to the prostate, hyperplasias and squamous metaplasias were detected in epithelia of the epididymis, vas deferens, coagulating gland, preputial gland and salivary gland. However, and in contrast to a recent study, no lesions reminiscent of highgrade prostate intraepithelial neoplasia were detected. Since b-catenin was activated in several cell types and impinged upon the viability of these mice, it was not possible to evaluate the cumulative effect over more than 3 months. To assess long-term consequences of b-catenin activation, mutant and control prostate tissues were transplanted into the mammary fat pads of wild-type males. Notably, squamous metaplasias, intra-acinous hyperplasia and possible neoplastic transformation were observed after a total of 18 weeks of b-catenin stimulation. This suggests that the transdifferentiation into squamous metaplasias is an early response of endodermderived cells to b-catenin, and that the development of Introduction b-Catenin is an integral part of the Wnt signaling pathway and has been linked to developmental processes including cell fate specification, polarity and migration (McCrea et al., 1991; Gat et al., 1998; Brault et al., 2001; Merrill et al., 2001; Niemann et al., 2002) . Wnt proteins bind to Frizzled receptors and induce a signaling cascade that leads to the stabilization of bcatenin. The stabilized b-catenin is able to interact with the lymphoid enhancer transcription factors (LEFs) and T-cell factors (TCFs), which subsequently activate genetic programs (Roose et al., 1999; de Lau and Clevers, 2001; Hovanes et al., 2001) . Genetic loss and gain of function experiments (Haegel et al., 1995; Gat et al., 1998; Huelsken et al., 2000 Widelitz et al., 2000) have revealed the importance of b-catenin in the determination of the anterior-posterior axis and mesoderm structures during fetal development, and its role in the specification of cell fate. Furthermore, b-catenin signaling is essential for the follicular differentiation of epidermal cells and the expression of a stabilized bcatenin in these cells results in the formation of unscheduled hair follicles (Gat et al., 1998) . In support of this observation, an epidermal fate is adopted by stem cells in the skin in the absence of b-catenin . Such lineage decisions appear to be regulated through specific genetic programs initiated by TCF3/LEF complexes (Merrill et al., 2001) . Recently, we demonstrated that the stabilization of b-catenin in differentiated mammary epithelium results in a loss of differentiation and the transdifferentiation into epidermal-like structures , further demonstrating the ability of this signaling pathway to determine cell fate.
Aberrant signaling through b-catenin has been found in many tumors, in particular those of the colon (e.g. Polakis, 2000) . Mutations in the b-catenin pathway have been observed in approximately 5% of human prostate cancers (Voeller et al., 1998; Chesire et al., 2000) and there is evidence to suggest that aberrant b-catenin signaling contributes to prostate growth and tumorigenesis (Chesire et al., 2002; Gerstein et al., 2002) . To establish whether tumorigenesis in the prostate can be induced by activated b-catenin alone, mice (Catnb
) were generated (Harada et al., 1999 ) that express stabilized b-catenin in prostate epithelium upon Cremediated excision of exon 3 (amino acids 5-80). Deletion of exon 3 in several cell types, including prostate epithelium, vas deferens, coagulating gland, preputial gland, basal cells in skin and salivary epithelium, was achieved through the use of transgenic mice that carry the Cre gene under the control of the MMTV-LTR ). To determine the cellular changes induced by b-catenin immunohistochemical approaches and microarray analyses were used to identify proteins and genes, respectively, whose expressions were altered.
Results

Stabilization of b-catenin in different tissues
Exon 3 of the b-catenin gene (amino acids 5-80) encodes critical serine and threonine residues that, upon phosphorylation, target the b-catenin protein for ubiquitin-mediated degradation. Mice have been generated that carry exon 3 of the b-catenin gene flanked by loxP sites. Using these mice, it has been demonstrated that Cre-mediated loss of exon 3 specifically in the intestine results in the generation of a truncated stabilized b-catenin and the formation of intestinal polyposis (Harada et al., 1999) . To further assess the consequence of b-catenin stabilization in other cell types, the conditionally targeted b-catenin mice were crossed with a mouse line expressing the Cre transgene under the control of the MMTV-LTR , which is referred to as Catnb +/Dex3 :MMTV cre mice Catnb +/Dex3 :MMTV cre mice could be identified visually at 10 days of age because they exhibited sparse and irregular hair growth (data not shown). In addition, these mice developed thickness of the eyelids, nose and ears within 6 weeks after birth (data not shown). An increase in the number of hair follicles and the presence of epithelioid cysts was observed (data not shown) similar to transgenic mice expressing stabilized b-catenin under the control of a K14 promoter (Gat et al., 1998) . To monitor the deletion of exon 3, the appearance of truncated b-catenin protein was analysed by way of western blots. As shown in Figure 1 , b-catenin was present in all tissues examined. The truncated form of bcatenin was evident in skin, salivary gland, epididymis, vas deferens, coagulating gland, seminal vesicle, ventral prostate (Figure 1a ), spleen and mammary tissue (data not shown) of Catnb +/Dex3 :MMTV cre mice. The appearance of N-terminal truncated b-catenin in these tissues is consistent with the cell-specificity of Cre activity in MMTV-Cre transgenic mice ).
Stabilization of b-catenin causes hyperproliferation and squamous transdifferentiation of prostate epithelium
Histological analysis of the ventral prostate from Catnb +/Dex3 :MMTV cre mice at 8 weeks of age revealed papillary epithelial hyperplasias and evidence of epithelial cells growing into the ductal lumina (Figure 2a ). Some ducts were filled with epithelial cells (Figure 2a ) and also contained extensive squamous metaplasias (Figure 2b ), which were similar to those observed in the mammary tissue expressing stabilized b-catenin . Furthermore, comparable to mammary tissue, the early lesions were characterized by an abundance of ghost cells (Figure 2b ). Prostate tissue from littermates that did not carry the Cre transgene exhibited normal histology consisting of regular acini and ducts and normal nuclei (Figure 2c ). By 12 weeks of age, the majority of prostate epithelium had undergone squamous transdifferentiation (Figure 2d and e). Extensive transdifferentiation was also observed in the preputial gland (Figure 2f ).
Tissue from eight mutant mice was examined (7.5-12 weeks of age) and all sampled lobes of the prostate and submucosal glands of the internal urethra were involved with a diffuse proliferative process of the epithelium. This process was associated with a diffuse interstitial infiltrate of lymphocytes and plasma cells (chronic inflammation). Loss of normal differentiation of the prostatic epithelium was observed and the glands were filled with highly mitotic densely crowded cells that had large, slightly pleomorphic hyperchromatic nuclei with relatively deficient cytoplasm. As the glands became filled with cells, the epithelium developed distinct multiple layers and formed back-to-back (cribriform) structures within the ducts. The most striking element was the tendency to form small foci of multilayered squamous cells. These foci were associated with the production of keratin swirls and hyalinized hard keratin. Keratohyalin granules were seen in the cytoplasm of To establish on a molecular level whether the prostate epithelium had undergone a transdifferentiation process and acquired epidermal markers, immunohistochemistry was performed with antibodies against keratin 1, keratin 5 and keratin 6 as well as b-catenin. While keratin 1 and keratin 6 were not expressed in prostate epithelium from wild-type mice (data not shown), keratin 5 was detected in the epithelial lining of acini and ducts (data not shown). This is consistent with the expression pattern of keratin 5 in human prostate (Achtstatter et al., 1985) . In Catnb +/Dex3 :MMTV cre mice, however, keratin 6 was detected in cells with a close proximity to those overexpressing b-catenin (Figure 2j and g). Keratin 1 expression also coincided with elevated levels of b-catenin (Figure 2k and h), while keratin 5 was localized not only in the single layer of cells surrounding the acini but also in more central cells (Figure 2l and i), which was confirmed by serial sections. This pattern of keratin expression was similar to that observed in the bcatenin-induced transdifferentiation of mammary tissue, which we described previously . To further establish that prostate epithelium had acquired biochemical features of epidermal differentiation, the presence of filaggrin, loricrin and involucrin was established. Filaggrin is normally detected in the stratus corneum, loricrin in the granular layer and involucrin in the spinous layer of the skin (Fuchs and Byrne, 1994) . While no expression was observed in normal prostate tissue (data not shown), extensive expression of loricrin and involucrin ( Figure 2m and n), but not filaggrin (Figure 2o ), was observed in prostate tissue upon the stabilization of b-catenin. Taken together, and in agreement with the previous study in the mammary gland , detection of several epidermal markers provides compelling evidence that the continuous presence of b-catenin in prostate epithelium results in the transdifferentiation into epidermal-like structures.
Identification of genes deregulated upon the stabilization of b-catenin
To identify genes that are either induced or repressed upon the stabilization of b-catenin, we monitored gene expression using cDNA microarrays. The 12.6k microarray contained genes from the NCI oncochip (GEM1) and all of the clones from the LGP mammochip . RNA was prepared using prostates from four 8-week-old transgenic mice and four control littermates, labeled and used for hybridization. Out of the 12 600 on the array, 92 genes were differentially expressed with a ratio of three-fold or greater (51 were higher in the transgenic mice and 41 were lower). Out of those, 24 were known genes and 68 were unknown ESTs (Table 1) . Interestingly, expression of eight genes, including IMAGE clones 1493858, 947821, 1511503, 1382204, 1348833 and 1246820 were induced not only in prostate epithelium upon stabilization of b-catenin, but also in squamous metaplasias observed in the mammary epithelium following bcatenin stabilization (Renou et al., submitted) .
To determine whether expression of these differentially regulated genes was linked to specific cell types and the development of neoplasias, the entire EST database containing in excess of 2 000 000 clones was screened. NKCC1 and lactotransferrin were found predominantly in cDNA libraries from neoplastic mammary tissue, whereas expression of SPRR2A was largely confined to colon libraries. A total of 50 matches were found for Ratios pseudocolor scale
Stabilized b-catenin induces squamous transdifferentiation B Bierie et al lactotransferrin, with 37 of them in a single library prepared using mammary hyperplasias from transgenic mice overexpressing TGFa in mammary epithelium (Humphreys and Hennighausen, 1999) . These findings suggest that the expression of these genes is also associated with hyperplastic epithelium from other tissues and not confined to the hyperplastic transdifferentiating prostate. To verify the results from the microarray experiments, Northern blot analyses and immunohistochemistry were performed with several known genes, whose expression was induced in bcatenin transformed prostate tissue. RNA levels for lactotransferrin (LTF), small proline-rich protein 2A (SPRR2A), neuroepithelial cell transforming gene 1 (NET1) and amyloid beta precursor-like protein 2 (APLP2) were highly elevated in mutant prostate tissue, in agreement with the microarray data ( Figure 3 ). Hybridization to GAPDH mRNA was used as a loading control. Genes whose expression is altered in transdifferentiated tissue may not be under direct control of bcatenin, rather the deregulation might be a consequence of a changed ratio of cell types or an altered physiological state of the animal. In order to identify early physiological and transcriptional changes induced by stabilized b-catenin, a cell-based system was used that permitted a temporal activation of b-catenin. The deletion of exon 3 in mouse embryonic fibroblast (MEF) cultures from Catnb +/Dex3 mice was induced with a retrovirus-based Cre recombinase (Krempler et al., 2002) . The presence of stabilized b-catenin was detected within 48 h after infection (Figure 4b , lane 4). RNA from Catnb +/Dex3 cells that had been infected with the retrovirus and RNA from Catnb +/Dex3 cells without retroviral infection were used for array analysis ( Table 2) . Out of 17 genes exhibiting significant changes in expression level, a total of 11 were induced upon bcatenin activation including the one encoding TGFb2. None of the genes induced in the cell culture system were activated in the transdifferentiated prostate tissue. These results suggest that either the response to b-catenin is cell-specific or all of the changes that we have observed in the prostate are secondary effects of the transdifferentiation process or expressed by the invading inflammatory cell types.
Stabilization of b-catenin causes the loss of normal prostate epithelial characteristics Expression of several genes, including the gene encoding the sodium potassium chloride cotransporter NKCC1 was lower in mutant prostate as compared to wild-type prostate. The presence of NKCC1 has been linked to the differentiation status of mammary epithelium (Miyoshi et al., 2001; Shillingford et al., 2002a, b) and it can be hypothesized that the reduced expression upon stabilization of b-catenin was linked to a loss of differentiation. Immunohistochemical experiments established the presence of a homogeneous distribution of NKCC1 protein at the basolateral membrane of prostate epithelial cells in the wild-type animal (Figure 5b ), similar to that observed in mammary epithelial cells in virgin mice (Shillingford et al., 2002b) . In contrast, expression of NKCC1 in prostate epithelium from Catnb +/Dex3 :MMTV cre mice was heterogeneous and its absence was associated with cells that exhibited elevated b-catenin levels (Figure 5a , a 0 and a 00 ). The observed reduction in NKCC1 expression supports the results of the microarray analyses, and the restricted loss of NKCC1 in areas of b-catenin activation supports the notion that these cells have lost their normal status of differentiation.
It has been proposed that the signal transducer and activator of transcription 5a (Stat5a) plays a critical role not only in mammary development (Liu et al., 1997; Miyoshi et al., 2001) but also in the maintenance of normal tissue architecture and function of the mouse prostate (Nevalainen et al., 2000) . In this context, the stabilization of b-catenin resulted in the suppression of Stat5a expression (Figure 5c , c 0 and c 00 ) while homogeneous nuclear staining was observed in wild-type prostate epithelium (Figure 5d, d 0 and d 00 ). Collectively, these findings suggest that the initial b-catenin stabilization results in the loss of normal prostate epithelial characteristics followed by the formation of hyperplasias and transdifferentiation into squamous metaplasias.
Neoplastic progression of mutant prostate epithelium upon transplantation MMTV-Cre-mediated activation of b-catenin also resulted in severe skin lesions and mice had to be killed no later than 3 months of age. Thus it was not possible to investigate the temporal progression of the hyperplasias and metaplasias. In addition, this model did not permit a distinction of systemic and cell autonomous effects. To overcome these obstacles, ventral prostate tissue from 9-week-old mutant mice (Catnb +/Dex3 :MMTV cre and Catnb +/Dex3 ) was transplanted into cleared mammary fat pads of 3-week-old wild-type males. This permitted the evaluation of the consequences of activated bcatenin at later timepoints. After the transplantation, mutant and control tissues were maintained for an additional 9 weeks before they were harvested ( Figure  6a (Figure 6c and f) . In contrast to the controls, the Catnb +/Dex3 :MMTV cre transplants had a thick encapsulation that surrounded the prostatic epithelium (Figure 6a and b ). There were four types of morphological identities adopted by the encapsulated mutant prostatic tissues. The first morphological identity was a normal single cell layer surrounding a lumen (data not shown), the second morphology were small hyperplastic nodules that extended into the lumen from the alveolar surface (data not shown), the third identity was an accumulation of large intra-acinous hyperplastic nodules that extended into the lumen (Figure 6d ), and the last was the filled lumen consisting of hyperplastic epithelial cells with circular occlusions and occasional keratin deposits (Figure 6e ). The hyperplastic nodules in the Catnb +/Dex3 :MMTV cre transplants demonstrated high levels of b-catenin accumulation (Figure 6g , j, m and p). Keratin 5 expression was not altered (Figure 6h ), but NKCC1 expression was dramatically decreased in the areas of b-catenin accumulation (Figure 6k ). Interestingly, expression of keratins 1 and 6 in the transplants was low (Figure 6n and q, respectively) . The decrease of keratins 1 and 6 in the prostate after transplantation suggests a dominance of hyperproliferation over squamous metaplasia formation upon extended accumulation of b-catenin.
Stabilized b-catenin induces epithelial hyperplasias in the vas deferens, epididymis, coagulating gland, seminal vesicle and salivary gland As shown in Figure 1 , stabilized b-catenin was also detected in the vas deferens, epididymis, coagulating gland, salivary gland and seminal vesicle. Although the overall histological appearance of these organs from 8-week-old mice was normal (Figure 7a-e) , immunohistochemical analyses revealed areas containing excessive b-catenin accumulation. In addition, cells in these areas had undergone proliferation and were positive for keratin 5 (Figure 7a 00 -e 00 ). Interestingly, and unlike the prostate, no keratin 1 or keratin 6 expression was observed in these tissues from Catnb +/Dex3 :MMTV cre or wild-type mice (data not shown). It is not clear at this point whether these lesions may continue to proliferate and undergo transdifferentiation at a later timepoint. Stabilization of b-catenin in epithelial cells of the preputial gland resulted in a complete squamous transdifferentiation by 12 weeks of age (Figure 2f ).
Stabilization of b-catenin in prostate epithelium leads to the activation of matrix metalloproteinase 9 (MMP9)
The presence of areas containing hyperplasias and squamous metaplasias suggested the occurrence of tissue remodeling. To investigate the nature of remodeling during the transdifferentiation process, the activity of metalloproteinases was monitored in zymogram gels (Figure 8 ). Strong activation of MMP9 was detected in the ventral prostate from Catnb +/Dex3 :MMTV cre mice, where hyperplasias and squamous transdifferentiation of epithelial cells had been observed. In contrast to MMP9, we observed no difference in MMP2 activity, and this would suggest that rather than secretion by inflammatory cell types, the altered MMP9 expression is due to the stabilization of b-catenin. The presence of increased MMP9 activity in the prostate from Catnb +/
Dex3
:MMTV cre mice may indicate an elevated potential for the expansion of hyperplastic areas. Further, the overexpression of active MMP9 has been linked to several tumor models (Baruch et al., 2001; Kallakury et al., 2001; Rodriguez-Manzaneque et al., 2001) , and this enzymatic activity may confer another growth advantage to an expanding population of squamous metaplastic or neoplastic cell types in vivo.
Discussion
Wnt/b-catenin signaling is involved in cell fate determination ) and activation of this pathway can result in the transdifferentiation of one cell type into an unrelated one, as demonstrated by our previous work in the mammary gland (Miyoshi et al., 2002a and c) . While the ectopic expression of stabilized b-catenin in the basal cells of the skin promotes de novo formation of hair follicles (Gat et al., 1998) , the inhibition of this pathway leads to conversion of hair follicles into interfollicular epidermis (Niemann et al., 2002) . In addition, the loss of b-catenin results in the establishment of cysts and progressive hair loss .
The current work demonstrates that the activation of b-catenin signaling in prostate epithelium led to hyperplasias and transdifferentiation into squamous β-cat K6 Figure 6 Transplants from Catnb +/Dex3 :MMTV cre prostate tissues demonstrate the preferential enrichment of hyperplastic intraacinous growth over squamous transdifferentiation. H&E staining from transplanted Catnb +/Dex3 :MMTV cre and Catnb +/Dex3 ventral prostate tissues in the cleared stromal compartment of the male mammary gland (a-f). The Catnb +/Dex3 :MMTV cre prostates displayed numerous foci of intra-acinous hyperplasia and areas of filled lumina surrounded by a relatively thick encapsulation (a and b, d and e). The control transplants displayed a morphology that was similar to the endogenous ventral prostate (c and f). Markers keratin 5 and NKCC1 demonstrated similar expression to the endogenous mutant prostate (h and k, respectively). The expression of keratin 1 and keratin 6 was altered (n and q, respectively) from the endogenous mutant glands when compared to tissues from 7.5 to 12 weeks of age. The dominant signal from keratin 1 (n) occurred in the centriacinar keratin deposits, but some of the cells continued to produce this marker (data not shown). b-Catenin (g, j, m and p) was separated from each merged image (i, l, o and r) to show the individual contribution for each marker This may be the result of cell cycle-associated fluctuations in b-catenin levels, or a reduction of b-catenin levels once the cellular phenotype has been altered towards hyperplasias and metaplasias. This study demonstrates that functional prostate epithelium has the capacity to adopt a differentiation program that is unrelated to the lineage it is derived from. The plasticity of epidermal stem cells has been recognized (Gat et al., 1998; Watt and Hogan, 2000; Merrill et al., 2001) , and there are examples that the fate of neuronal and hematopoietic cells can be diverted even after the establishment of particular programs of differentiation (Kondo et al., 2000; Ross et al., 2000) . In the prostate, such reprogramming of cells can be facilitated simply through the prolonged induction of b-catenin. Therefore it appears that Wnt/b-catenin signaling is dominant even over existing differentiation programs initiated in both mammary and prostate epithelium. However, the extent to which b-catenin signaling can induce proliferation and transdifferentiation is cell-specific. Thus while the stabilization of b-catenin in mammary epithelium leads almost exclusively to the formation of squamous metaplasia , both hyperplasias and squamous metaplasias were observed in the prostate as shown here. In contrast, adenomatous polyps were observed in the intestine (Harada et al., 1999) . The lack of observable neoplasias and tumors in hepatocytes expressing a stabilized b-catenin (Harada et al., 2002) further supports the concept of the cellspecific nature of b-catenin signaling. Recently, Gounari et al. (2002) reported the extensive presence of high-grade PIN-like lesions in mouse prostate epithelium upon the stabilization of b-catenin. This observation is in contrast to the current study in which we failed to find evidence of such lesions in a total of eight mice, which ranged in age between 8 and 12 weeks. Although it appears unlikely that strain differences can account for such variability given that the source of the b-catenin mice and MMTV-Cre mice was the same, subtleties in strain background cannot be ruled out. One possible explanation for the differences could be the duration of b-catenin activation and possible secondary effects. While predominantly squamous metaplasias were observed in 8-12-week-old mice, Gounari observed high-grade PIN-like lesions in mice ranging from 10 to 21 weeks of age. MMTV-Cremediated deletion of exon 3 of the b-catenin gene occurs not only in mammary and prostate epithelia but also in a number of other cell types, including skin and immune cells. The physiological consequences are profound and we had to kill the mice at 3 months of age. A transplantation approach permitted the evaluation of long-term consequences of b-catenin activation in the absence of systemic effects. Under these experimental conditions hyperplasias, possible neoplasias and squamous metaplasias were detected. This observation suggests that the cumulative activation of b-catenin can lead to distinct cellular lesions. We therefore hypothesize that an early event is the transdifferentiation of prostate epithelium into squamous metaplasias. However, cells, which escape the transdifferentiation process, can progress into intra-acinous hyperplasias with the possibility of neoplastic transformation.
The development of squamous metaplasias from endoderm-derived cells implies an erasure of several steps of developmental commitment, but the cell-specific executors of this conversion remain to be defined. The gene discovery efforts emerging from this study might provide information on mechanisms that result in the loss of differentiation and the acquisition of an epidermal fate. We identified known and unknown genes with increased levels of expression in the transdifferentiated prostate. Some of these genes were also induced in transdifferentiated mammary tissue, further supporting the notion that activated b-catenin induces an epidermal fate in both cell types. Among the genes activated in transformed prostate tissue were those encoding lactotransferrin, SPRR2A, NET1 and APLP2. High levels of lactotransferrin have been detected in neoplastic cells and differentiated adenocarcinomas of the prostate, but not in undifferentiated carcinomas (Barresi and Tuccari, 1984) . Since lactotransferrin levels are increased upon inflammation of the human prostate gland (Reese et al., 1992) and high levels are detected in lymphocytes, it is possible that the expression in prostate tissue upon b-catenin stabilization reflects both hyperplasias and an immune response. It is worth noting that other genes linked to immune cell activity are also activated, including the lymphocyte antigen 6 complex and WM65 k-immunoglobulin (Table 1) . SPRR2A is a member of the cornified cell envelope precursors in the same subclass as loricrin, involucrin and the other SPRRs (Fischer et al., 1998) . The expression of SPRR2A is confined to squamous and glandular epithelia such as the mammary gland, prostate, salivary gland and kidney (Oettgen et al., 1999) . In addition, SPRR2A has been associated with terminal keratinocyte differentiation, and its regulation may be coordinated with other genes such as profilaggrin in forming the epidermal differentiation complex (Fischer et al., 1998) . SPRR2A is a structural component of the cornified cell envelope of squamous epithelia (Song et al., 1999) Treisman, 1998) , is an important mediator of stress fiber formation in TGFb-mediated signaling (Shen et al., 2001) . TGFb has been shown to induce NET1 expression (Shen et al., 2001) and its levels were induced within 48 h after b-catenin activation. Thus, the early induction of TGFb may infer the effects of an activated downstream signal during the initial stages of b-catenin accumulation. Lastly, APLP2 is a ubiquitously expressed secreted protein (Slunt et al., 1994) , which has been implicated in cell motility toward fibronectin and collagen with an increase in the affinity to bind these substrates (Li et al., 1999) . In summary, by 8 weeks of age the activation of bcatenin has resulted in diffuse hyperplasia of the prostate and submucosal glands of the urethra with extensive squamous metaplasias that produce cellular hard keratins. This pattern is strikingly similar to that seen upon stabilization of b-catenin in mouse mammary tissue . Subsequent transplantation of transformed prostate tissue into a wild-type host resulted in the development of hyperplastic and possible neoplastic foci as well as squamous metaplasia after an additional 2 months. These results suggest that the activation of b-catenin leads to progressive cellular changes, which includes hyperplasias, squamous metaplasias and a subsequent shift toward neoplastic transformation.
Materials and methods
Generation of constitutively active b-catenin
The floxed b-catenin mice and MMTV-Cre transgenic mice have been described Harada et al., 1999) . Mice containing one wild-type b-catenin allele and one conditional allele (Catnb +/lox(ex3) ) were mated with the MMTV-Cre mice to generate Catnb +/lox(ex3) :Tg:MMTV cre mice (referred to as Catnb +/Dex3 :MMTV cre mice).
Western blotting
Protein was isolated from each tissue as previously described (Liu et al., 1996) . A total of 40 mg of protein was separated by electrophoresis in Tris-glycine gels (Invitrogen, Carlsbad, CA, USA). Membranes were blocked overnight at 41C in TBST (Tris-buffered saline. pH 7.4, with 0.05% Tween 20) containing 5% (wt/vol) nonfat dried milk. Primary mouse monoclonal anti-b-catenin (Transduction Laboratories, Lexington, KY, USA) was applied at 1 : 1000 and incubated with the membranes for 1 h at room temperature. Subsequently, membranes were incubated with a horseradish peroxidase (HRP)-linked anti-mouse antibody for 30 min at room temperature. Specifically bound secondary antibodies were visualized using an enhanced chemiluminescence procedure (Pierce Chemical, Rockford, IL, USA).
Histology and immunohistochemistry
Each tissue was isolated from Catnb +/Dex3
:MMTV cre mice and fixed in Telly's fixative for 4 h. After fixation, samples were dehydrated, embedded in paraffin and sectioned at 5 mm. For histology, sections were stained with hematoxylin and eosin. For immunohistochemistry, the primary antibodies were obtained from the following sources: rabbit polyclonal antiStat5a (Liu et al., 1996) , rabbit polyclonal anti-keratin 1 (Babco. Richmond, CA, USA), rabbit polyclonal anti-keratin 5 (Babco) and rabbit polyclonal anti-keratin 6 (Babco). To detect the primary antibodies fluorochrome conjugated antimouse (Alexafluor 488) and fluorochrome conjugated antirabbit (Alexafluor 594) secondary antibodies (Molecular Probes) were used for immunohistochemistry. The primary antibodies (keratin 1, 1 : 200; keratin 5, 1 : 200; keratin 6, 1 : 200; b-catenin, 1 : 100; NKCC1, 1 : 1000; Stat5a, 1 : 600) were applied to the sections and incubated at 371C for 1 h. Sections were subsequently incubated with fluorescent-conjugated anti-mouse and anti-rabbit secondary antibodies at 371C for 1 h. An HRP-conjugated anti-rabbit antibody was used for the detection of rabbit polyclonal anti-involucrin (Babco 1 : 1000), rabbit polyclonal antiloricrin (Babco, 1 : 500), and rabbit polyclonal antifilaggrin (Babco, 1 : 1000) using an appropriate ABC kit (Vector Laboratories, Inc., Burlingame, CA, USA) following the manufacturer's protocol. To visualize the bound antibodies, we used a DAB kit (Vector Laboratories, Inc., Burlingame, CA, USA) as described by the manufacturer's protocol excluding addition of the nickel substrate. The slides were counterstained with hematoxylin, dehydrated and mounted using Permount (Fisher Scientific).
Microarray analysis
The microarray analyses were performed with a 12.6k containing cDNAs from the NCI oncochip (GEM1) and from the mammochip . RNA was prepared from prostates of four 8-week-old transgenic mice and four control littermates using TRIzol extraction (Life Technologies, Rockville, MD, USA) followed by two ethanol precipitations. RNA from the four mice was pooled for the array analysis. From the MEF cultures, three individual plates were pooled for RNA in each of two replicate experiments. RNA was then prepared from the individual pools using TRIzol followed by two ethanol washes. For fluorescence labeling, 20 mg of total RNA were reverse transcribed in presence of 300 U of SS II (Life Technologies, Rockville, MD, USA) and labeled with cy3-dUTP and cy5-dUTP (MEN, Boston, MA, USA). Samples were combined, purified and concentrated with YM30 Microcon columns (Millipore, Bedford, MA, USA). Slides were prehybridized for 1 h and hybridized overnight at 421C, in 25% formamide. Slides were washed in 2 Â SSC/0.1% SDS 4 0 , 1 Â SSC 4 0 , 0.2 Â SSC 4 0 , 0.05 Â SSC 1 0 , dried by centrifugation, and scanned on a GenePix 4000A scanner (Axon Instruments, Foster City, CA, USA). The images were analysed by GenePix Pro 3.0 (Axon Instruments, Foster City, CA, USA). Each experiment was repeated with switching the labeling. The data were deposited in the NCI-CIT microarray database and normalized data were analysed with the included 'mAdb tools' with some modifications: the differentially expressed genes were selected by signal intensity of fivefold over the average slide background in at least one channel and an expression ratio of 3/0.3 or higher. These criteria had to be met also in the reverse-labeled experiments.
Northern blot analysis RNA preparation has been described in the microarray section, and 20 mg of total RNA was loaded for each sample. The Northern blots were performed as described previously (Robinson et al., 1995) . Primers for cDNA probes were produced as purified PCR fragments from the following 
0 -F GAPDH R-5 0 CCACCACCCTGTTGCTGTAG3 0 -R. All of the probes were sequenced prior to hybridization to ensure accuracy of the PCR fragment.
MEF preparation and Cre excision in vitro
MEFs were derived from 14-day-old embryos with the genotype of Catnb +/Dex3
. The 14-day-old embryos were isolated, the heads were removed and the liver was removed with the other internal organs. The remaining tissue for each embryo was placed in 1 ml of trypsin/EDTA (Gibco) mashed briefly with a pipette tip and incubated for 10 min at 371C. A volume of 10 ml of MEF medium (DMEM 500 ml (Gibco), penicillin+streptomycin 3 ml (Gibco), nonessential amino acids 6 ml (Gibco), l-glutamine 10 ml (Gibco), fetal calf serum 90 ml (Gibco), 2-mercaptoethanol 4 ml (Sigma)) was added to the tissue, triturated with a pipette tip and plated on 10 cm culture dishes. After overnight incubation at 371C in 5% CO 2 , the medium was changed and the cells were passed the following day. After the cells had reached 50% confluence, they were infected with a pBabe retro-Cre construct (Krempler et al., 2002) in the presence of 1 mg/ml polybrene with a volume of 4 ml MEF medium. After the initial incubation, 1 ml of the same virus solution was added and incubated for 2 h. Finally, the last 1 ml of virus was added to the plate and incubated for 2 h. A volume of 6 ml of MEF medium was added to each dish and incubated overnight. The next day the medium was aspirated and 10 ml of fresh MEF medium was added to each plate then allowed to incubate overnight. Puromycin (Sigma) was used at 2.5 mg/ml in MEF medium for a selection lasting 18 h. After selection, the cells were collected for protein and RNA analysis. Deletion efficiency was visualized by the appearance of a truncated b-catenin protein by Western blot.
Transplantation of prostate tissues
The recipients were athymic nude mice that had been kept in a sterile facility. The mammary fat pad was cleared at 3 weeks of age (DeOme et al., 1959) . The fourth and fifth inguinal glands were separated by cauterization, and the blood supply to the fourth gland was also cauterized below the lymph node before excision of the tissue from the nipple to the lymph node. The nipple was then cauterized from the inside to ensure that no new epithelial growth could occur. All excised tissues were kept and analysed to ensure that all of the epithelium had been cleared (after a standard whole-mount stain using carmine alum). The donor tissues were collected from Catnb +/Dex3 and Catnb +/Dex3 :MMTV cre littermates at 9 weeks of age. The ventral prostate was excised and placed into 1 Â PBS. Prostate tissues were minced into small pieces (about 1 mm 3 ) and then surgically inserted into the fourth inguinal gland of the recipient through a small incision in the fat pad. In order to minimize small systemic variations in the different recipients, each host had both a control and contralateral mutant transplant. The mammary fat pads were collected after 9 weeks of growth within the recipients. The tissues were then fixed and stained using the same protocols as the endogenous glands stated in the Histology and immunohistochemistry section.
Zymogram gel analysis
Coomassie-stained casein and gelatin zymogram SDS-PAGE were carried out essentially as described in the manufacturer's protocol (Invitrogen, Carlsbad, CA, USA). The lysate was loaded with 40 mg of protein per well. Zymography was carried out on gelatin-embedded 10% Tris-glycine gels (Invitrogen, Carlsbad, CA, USA). The gel was fixed after zymogram developing for 2 h in 50% methanol, 10% acetic acid, stained overnight in 50% methanol, 0.05% brilliant cresyl blue, and destained in 5% methanol, 7% acetic acid until the background cleared. The gel was dried according to the manufacturer's protocol (Research Products International Corporation, Mount Prospect, IL, USA).
Abbreviations EST, expressed sequence tag; LTR, long terminal repeat; MMP, matrix metalloproteinase; MMTV, mouse mammary tumor virus; Stat, signal transducer and activator of transcription.
